Posted on 23 July 2013

Pfizer decided not to pursue a bid for Onyx Pharmaceuticals this week, according to two people familiar with the matter, leaving Amgen in the front position to buy the cancer drugmaker Read the full story

Posted on 16 July 2013

Gilead Sciences announced over 60 partnering / licensing deals since 2005, with 20 deals in 2006 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in infectives diseases Read the full story